| Patents for C07C 405 - Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins (3,702) |
|---|
| 10/31/2012 | CN102757459A Intermediate for synthesizing prostaglandin medicament and preparation method of intermediate |
| 10/31/2012 | CN101704777B Method for removing trans isomers with double bond at 5,6-positions from prost compounds |
| 10/23/2012 | CA2601096C Treatment of inflammatory bowel disease |
| 10/18/2012 | WO2012139164A1 Polymer conjugated prostaglandin analogues |
| 10/18/2012 | CA2832886A1 Polymer conjugated prostaglandin analogues |
| 10/04/2012 | WO2010109476A3 Improved process for the preparation of prostaglandins and analogues thereof |
| 10/03/2012 | EP2504313A1 7-[3,5-dihydroxy-2- (3-hydroxy-5-phenyl-pent-1-enyl)- cyclopentyl]-n-ethyl-hept-5-enamide (bimatoprost) in crystalline form ii, methods for preparation, and methods for use thereof |
| 10/03/2012 | CN102712584A 7-[3,5-dihydroxy-2- (3-hydroxy-5-phenyl-pent-1-enyl)- cyclopentyl]-n-ethyl-hept-5-enamide (bimatoprost) in crystalline form ii, methods for preparation, and methods for use thereof |
| 09/26/2012 | CN102690219A Method for purifying bimatoprost |
| 09/25/2012 | US8273362 Cationic ophthalmic oil-in-water type emulsion; colloid particles, oily core surrounded by interfacial film; poloxamers, tyloxapol non ionic surfactant; prostaglandin is latanoprost, unoprostone isopropyl; chitosan, chlorhexidine, benzalkonium halide, vegetable oils; eye drops, ointment, ophthalmic gel |
| 09/12/2012 | EP2497766A1 A crystalline form of bimatoprost, preparation method and use thereof |
| 09/12/2012 | EP2496553A1 A novel process for the preparation of prostaglandins and intermediates thereof |
| 09/06/2012 | US20120225939 Use of Prostaglandins F2Alpha and Analogues for the Healing of Corneal and Conjunctival Lesions |
| 09/06/2012 | US20120225938 Method for treating central nervous system disorders |
| 09/05/2012 | EP2495235A1 Process for the synthesis of prostaglandins and intermediates thereof |
| 08/23/2012 | WO2012112451A1 Ester derivatives of bimatoprost compositions and methods |
| 08/23/2012 | CA2827446A1 Ester derivatives of bimatoprost compositions and methods |
| 08/16/2012 | US20120209011 novel process for the preparation of prostaglandins and intermediates thereof |
| 08/15/2012 | EP2487153A1 Substituted cyclopentanes having prostaglandin activity |
| 08/15/2012 | EP2114875B1 Substituted arylcylopentenes as therapeutic agents |
| 08/09/2012 | US20120202773 Pharmaceutical composition for treatment of diseases associated with decrease in bone mass comprising ep4 agonist as active ingredient |
| 08/08/2012 | EP1819670B1 12-aryl prostaglandin analogs |
| 07/31/2012 | CA2458471C Prostaglandin analogs as chloride channel opener |
| 07/26/2012 | US20120190620 Methods to identify targets and molecules regulating purinosomes and their uses |
| 07/12/2012 | US20120178798 Substituted cyclopentanes having prostaglandin activity |
| 07/11/2012 | EP1608309B1 10,10-dialkyl prostanoic acid derivatives as agents for lowering intraocular pressure |
| 07/11/2012 | CN102558009A Preparation method of prostaglandin derivative |
| 06/27/2012 | CN101486699B Prostaglandin synthesis |
| 06/26/2012 | US8207223 Pharmaceutical composition for treatment of diseases associated with decrease in bone mass comprising EP4 agonist as active ingredient |
| 06/20/2012 | CN102507767A Alprostadil and quality standard of preparation thereof |
| 05/08/2012 | USRE43372 C16 unsaturated FP-selective prostaglandins analogs |
| 05/08/2012 | CA2377661C Use of fatty acid derivative for the treatment of external secretion disorders |
| 05/01/2012 | US8168680 Cyclopentane heptan(ENE)OIC acid, 2-heteroarylalkenyl derivatives as therapeutic agents |
| 04/12/2012 | WO2011159740A3 Methods for manufacturing tetranor-prostaglandin d, j, e, a and f metabolites |
| 03/22/2012 | WO2011120474A9 Method for inhibiting hiv replication in mammal and human cells |
| 03/21/2012 | EP2429982A1 Methods of making lubiprostone and intermediates thereof |
| 03/07/2012 | EP1390036B1 Prostanoic acid derivatives as agents for lowering intraocular pressure |
| 02/16/2012 | US20120041229 Methods for manufacturing tetranor-prostaglandin d, j, e, a and f metabolites |
| 02/15/2012 | CN102351767A Alprostadil compound and preparation method thereof |
| 02/01/2012 | CN102336693A Carboprost tromethamine crystals, preparation method and application thereof |
| 01/26/2012 | WO2012011128A1 Preparation of prostaglandin derivatives |
| 01/26/2012 | WO2012010089A1 Preparation method for and uses of carboprost tromethamine crystal |
| 01/26/2012 | CA2805959A1 Crystals of carboprost tromethamine and the preparation method as well as the uses thereof |
| 01/12/2012 | WO2011095990A3 Process for the purification of prostaglandins and analogues thereof |
| 01/04/2012 | EP2401252A1 Process for the preparation of prostaglandin derivatives |
| 12/22/2011 | WO2011159740A2 Methods for manufacturing tetranor-prostaglandin d, j, e, a and f metabolites |
| 12/22/2011 | CA2802387A1 Methods for manufacturing tetranor-prostaglandin d, j, e, a and f metabolites |
| 12/15/2011 | WO2011154754A1 USE OF PROSTAGLANDIN F1α AND ITS DERIVATIVES FOR REDUCTION OF INFLAMMATION |
| 12/14/2011 | CN101003504B 用于制备前列腺素的方法和中间体 Methods for the preparation of prostaglandins and intermediates |
| 12/08/2011 | CA2777070A1 Treprostinil production |
| 12/01/2011 | US20110294893 Non-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents |
| 11/15/2011 | US8058467 Prostaglandin derivatives |
| 11/09/2011 | EP2384791A2 Method and composition for treating mucosal disorders |
| 11/09/2011 | EP2384790A2 Method and composition for treating mucosal disorders |
| 11/03/2011 | US20110269689 High penetration compositions and their applications |
| 10/06/2011 | WO2011120474A1 Method for inhibiting hiv replication in mammal and human cells |
| 10/06/2011 | CA2794930A1 Method for inhibiting hiv replication in mammal and human cells |
| 09/28/2011 | EP1673058B1 Composition and method for promoting hair growth |
| 09/21/2011 | EP2170819B1 Prostaglandin pharmaceutical compositions |
| 09/13/2011 | US8017655 Non-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents |
| 08/23/2011 | US8003680 Therapeutic compounds |
| 08/11/2011 | WO2011095990A2 Process for the purification of prostaglandins and analogues thereof |
| 08/09/2011 | CA2445651C Cathartic composition comprising halogenated prostaglandin derivatives |
| 08/04/2011 | WO2011091513A1 Polymorphic forms of lubiprostone |
| 08/04/2011 | US20110189094 Biological method for in vivo tracking of molecules affecting cellular migration |
| 08/04/2011 | CA2788334A1 Polymorphic forms of lubiprostone |
| 08/03/2011 | EP2349242A2 Amino acid salts of prostaglandins |
| 07/28/2011 | US20110184192 Prostaglandin synthesis and intermediates for use therein |
| 07/21/2011 | US20110178340 Improved process for the production of bimatoprost |
| 07/20/2011 | CN102126998A Endothelin antagonist |
| 07/14/2011 | WO2011005505A3 Method for the purification of prostaglandins |
| 07/14/2011 | US20110172435 Treatment Of Inflammatory Bowel Disease |
| 07/05/2011 | CA2450466C 3, 7 or 3 and 7 thia or oxa prostanoic acid derivatives as agents for lowering intraocular pressure |
| 06/22/2011 | CN102101835A Prostaglandin derivative and preparation method of prostaglandin derivative intermediate |
| 06/15/2011 | CN102099330A Nitric oxide donating prostamides |
| 06/09/2011 | US20110136904 Prostaglandin derivatives |
| 05/26/2011 | WO2011063276A1 7-[3,5-dihydroxy-2- (3-hydroxy-5-phenyl-pent-1-enyl)- cyclopentyl]-n-ethyl-hept-5-enamide (bimatoprost) in crystalline form ii, methods for preparation, and methods for use thereof |
| 05/26/2011 | CA2781698A1 7-[3,5-dihydroxy-2-(3-hydroxy-5-phenyl-pent-1-enyl)-cyclopentyl]-n-ethyl-hept-5-enamide (bimatoprost) in crystalline form ii, methods for preparation, and methods for use thereof |
| 05/12/2011 | WO2011055377A1 A novel process for the preparation of prostaglandins and intermediates thereof |
| 05/12/2011 | CA2777352A1 A novel process for the preparation of prostaglandins and intermediates thereof |
| 05/11/2011 | CN102050812A 10,10-dialkyl prostanoic acid derivatives as agents for lowering intraocular pressure |
| 05/11/2011 | CN102050811A 10,10-dialkyl prostanoic acid derivatives as agents for lowering intraocular pressure |
| 05/11/2011 | CN102050808A Preparation method for prostaglandin intermediate |
| 05/11/2011 | CN102050772A Bimatoprost crystal as well as preparation method and purposes thereof |
| 05/11/2011 | CN102050771A Method for preparing prostaglandin derivative |
| 05/05/2011 | WO2011050638A1 A crystalline form of bimatoprost, preparation method and use thereof |
| 04/27/2011 | CN101318948B Lubiprostone1 crystal, preparation method and uses thereof |
| 04/26/2011 | CA2465103C Use of a prostaglandin derivative as an anti-pruritic agent |
| 04/26/2011 | CA2364948C C16 unsaturated fp-selective prostaglandins analogs |
| 04/20/2011 | EP2311820A1 Process for the purification of latanoprost by HPLC |
| 04/20/2011 | CN102020625A High-purity lubiprostone, preparation method and application thereof |
| 04/12/2011 | CA2274670C 15-keto prostaglandins as portal hypertension inhibitors |
| 04/06/2011 | EP2303836A1 Therapeutic cyclopentane derivatives |
| 04/06/2011 | CN102007098A Therapeutic substituted cyclopentanes |
| 03/23/2011 | EP2297085A2 Substituted arylcyclopentenes as therapeutic agents |
| 03/23/2011 | EP2297084A1 Therapeutic compounds |
| 03/22/2011 | US7910767 Prostaglandin derivatives |
| 03/22/2011 | CA2366637C Process for the preparation of prostaglandin precursors |
| 03/15/2011 | US7906552 Compounds for prodrug for bonding, using prostaglandins |
| 03/09/2011 | EP2291353A1 Therapeutic prostaglandin compounds used as ocular hypotensive agents |